Early High-Dose Vitamin D and Residual β-Cell Function in Pediatric Type 1 Diabetes

NCT05270343 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

198

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: Cholecalciferol (Vit D3) 400Unit Cap

Sponsor

Shanghai Jiao Tong University School of Medicine